Children's Oncology Group's 2023 blueprint for research: Development therapeutics

被引：3
|
作者：
Fox, Elizabeth [1 ]
Parsons, D. Williams J. [2 ]
Weigel, Brenda [3 ,4 ]
Dev Therapeutics Comm
机构：
[1] St Jude Childrens Res Hosp, Memphis, TN USA
[2] Baylor Coll Med, Texas Childrens Canc & Hematol Ctr, Houston, TX USA
[3] Univ Minnesota, Div Pediat Hematol & Oncol, Med Ctr, Minneapolis, MN USA
[4] Univ Minnesota, Div Pediat Hematol & Oncol, Med Ctr, Mail Code 484,420 Delaware St SE, Minneapolis, MN 55455 USA
来源：
PEDIATRIC BLOOD & CANCER | 2023年 / 70卷
关键词：
phase; 2; precision medicine; trial design; PATHWAY; TRIAL;
D O I：
10.1002/pbc.30563
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The Developmental Therapeutics Committee (DVL) identifies and develops new agents and treatment strategies for children/adolescents with cancer, through clinical and translational research. DVL has focused on evaluating the activity of targeted therapy and has evolved from trials with multiple histology strata to biomarker-selected phase 2 trials. These trials have included single-agent studies to evaluate agents such as cabozantinib in multi-disease cohorts, to trametinib, larotrectinib, and lorvotuzumab in disease-specific cohorts, as well as the pediatric Molecular Analysis for Therapy Choice (MATCH) study including multiple single agents targeted for biomarker-selected pediatric tumors. The ongoing vision and direction of DVL is to support the disease committees of COG to develop novel agents and combinations to advance the care of children with cancer.
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Children's Oncology Group's 2023 blueprint for research: Central nervous system tumors
    Leary, Sarah E. S.
    Onar-Thomas, Arzu
    Fangusaro, Jason G.
    Gottardo, Nicholas
    Cohen, Kenneth
    Smith, Amy
    Huang, Annie
    Haas-Kogan, Daphne
    Fouladi, Maryam
    PEDIATRIC BLOOD & CANCER, 2023, 70
  • [22] Children's Oncology Group 2023 blueprint: Nursing discipline
    Zupanec, Sue
    Herriage, Teresa
    Landier, Wendy
    COG Nursing Discipline, C. O. G. Nursing Discipline
    PEDIATRIC BLOOD & CANCER, 2023, 70
  • [23] Children's Oncology Group's 2013 blueprint for research: Radiation oncology
    Merchant, Thomas E.
    Hodgson, David
    Laack, Nadia N. I.
    Wolden, Suzanne
    Indelicato, Danny J.
    Kalapurakal, John A.
    PEDIATRIC BLOOD & CANCER, 2013, 60 (06) : 1037 - 1043
  • [24] Children's Oncology Group's 2023 blueprint for research: Surgery
    Gow, Kenneth W.
    Lautz, Timothy B.
    Malek, Marcus M.
    Cost, Nicholas G.
    Newman, Erika A.
    Dasgupta, Roshni
    Christison-Lagay, Emily R.
    Tiao, Gregory M.
    Davidoff, Andrew M.
    OG Surgery Discipline Comm
    PEDIATRIC BLOOD & CANCER, 2024, 71 (03)
  • [25] Children's Oncology Group's 2023 blueprint for research: Cellular therapy and stem cell transplantation
    Kitko, Carrie L.
    Bollard, Catherine M.
    Cairo, Mitchell S.
    Chewning, Joseph
    Fry, Terry J.
    Pulsipher, Michael A.
    Shenoy, Shalini
    Wall, Donna A.
    Levine, John E.
    PEDIATRIC BLOOD & CANCER, 2023, 70
  • [26] Children's Oncology Group's 2013 blueprint for research: Epidemiology
    Spector, Logan G.
    Ross, Julie A.
    Olshan, Andrew F.
    PEDIATRIC BLOOD & CANCER, 2013, 60 (06) : 1059 - 1062
  • [27] Children's Oncology Group's 2013 blueprint for research: Neuroblastoma
    Park, Julie R.
    Bagatell, Rochelle
    London, Wendy B.
    Maris, John M.
    Cohn, Susan L.
    Mattay, Katherine M.
    Hogarty, Michael
    PEDIATRIC BLOOD & CANCER, 2013, 60 (06) : 985 - 993
  • [28] The Children's Oncology Group's 2013 five year blueprint for research
    Adamson, Peter C.
    PEDIATRIC BLOOD & CANCER, 2013, 60 (06) : 955 - 956
  • [29] Children's Oncology Group's 2013 blueprint for research: Bone tumors
    Gorlick, Richard
    Janeway, Katherine
    Lessnick, Stephen
    Randall, R. Lor
    Marina, Neyssa
    PEDIATRIC BLOOD & CANCER, 2013, 60 (06) : 1009 - 1015
  • [30] Children's Oncology Group's 2013 blueprint for research: Nursing discipline
    Landier, Wendy
    Leonard, Marcia
    Ruccione, Kathleen S.
    PEDIATRIC BLOOD & CANCER, 2013, 60 (06) : 1031 - 1036
12345